ONCSQ — OncoSec Medical Cashflow Statement
0.000.00%
Last trade - 00:00- $0.00m
- -$1.39m
Annual cashflow statement for OncoSec Medical, fiscal year end - July 31st, USD millions except per share, conversion factor applied.
2018 July 31st | 2019 July 31st | 2020 July 31st | 2021 July 31st | 2022 July 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -39.1 | -30.3 | -42.3 | -45.2 | -34.2 |
| Depreciation | |||||
| Non-Cash Items | 13.4 | 4.58 | 5.12 | 5.63 | 3.01 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2.17 | -3.55 | 3.77 | -2.49 | -1.23 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -23.2 | -29 | -33.1 | -41.8 | -32.1 |
| Capital Expenditures | -0.065 | -0.01 | — | -0.8 | -0.245 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -23.2 | 23.2 | — | — | — |
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -23.3 | 23.2 | — | -0.8 | -0.245 |
| Financing Cash Flow Items | -3.76 | -1.21 | -2.22 | 0.547 | -0.041 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 38.9 | 27.2 | 28.4 | 68.2 | -1.16 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -7.64 | 21.3 | -4.79 | 25.6 | -33.7 |